News

Filter

US NRC rules sites can procure radium-223 dichloride for Algeta/Bayer's prostate cancer candidate

14-01-2013

Norwegian drug developer Algeta (OSE: ALGETA) this morning announced that the US Nuclear Regulatory Commission…

AlgetaAlpharadinBayerNorth AmericaOncologyPharmaceuticalradium-223 dichlorideRegulation

Back to top